Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Friday, Feb. 14, 2014, 110 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,636.40 to $128,200,000.00. Highlighted Stocks Traded by Insiders: PerkinElmer (PKI) - FREE Research Report Michas Alexis P who is Director at PerkinElmer sold 5,000 shares at $44.25 on Feb. 14, 2014. Following this transaction, the Director owned 100,067 shares meaning that the stake was reduced by 4.76% with the 5,000-share transaction. The shares most recently traded at $43.77, down $0.48, or 1.1% since the insider transaction. Historical insider transactions for PerkinElmer go as follows:
4-Week # shares sold: 15,000
12-Week # shares sold: 15,000
24-Week # shares sold: 21,805
The average volume for PerkinElmer has been 841,400 shares per day over the past 30 days. PerkinElmer has a market cap of $4.9 billion and is part of the health care sector and health services industry. Shares are up 6.67% year-to-date as of the close of trading on Friday. PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. The stock currently has a dividend yield of 0.64%. The company has a P/E ratio of 21.1. Currently there are 12 analysts that rate PerkinElmer a buy, no analysts rate it a sell, and 2 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on PKI - FREETheStreet Quant Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full PerkinElmer Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.